Tyler-Stone Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Tyler-Stone Wealth Management's BMY Position: Q2 2025 in Review
Tyler-Stone Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.55% in Q2 2025, selling an estimated $1.47K and leaving 5,389 shares worth $249K. The position accounts for 0.04% of the portfolio, ranked #293.
Tyler-Stone Wealth Management first reported a position in BMY in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.5M in Q2 2022. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Tyler-Stone Wealth Management held 5,389 shares of Bristol-Myers Squibb worth $249K as of Q2 2025.
- Tyler-Stone Wealth Management sold 30 Bristol-Myers Squibb shares in Q2 2025, an estimated $1.47K.
- Bristol-Myers Squibb made up 0.04% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #293 holding.
- Tyler-Stone Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 14 quarters since.
- Tyler-Stone Wealth Management's Bristol-Myers Squibb position peaked at $1.5M in Q2 2022.
- 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.